vTv Therapeutics (VTVT) Net Margin Growth (5y) (2019 - 2026)

vTv Therapeutics (VTVT) Net Margin Growth (5y) (2019 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn
7 Belite Bio 62.72 Bn 62.72 Bn -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn -
10 vTv Therapeutics 19.21 Mn 19.21 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 66,754.00
Dec 31, 2024 7.69 Mn
Mar 31, 2024 -5,414.00
Dec 31, 2022 -4.68 Mn
Jun 30, 2022 6.82 Mn
Mar 31, 2022 4.73 Mn
Dec 31, 2021 -9.32 Mn
Sep 30, 2021 3.55 Mn
Jun 30, 2021 127,576.00
Mar 31, 2021 299,372.00
Dec 31, 2020 -144,745.00
Sep 30, 2020 -2.48 Mn
Mar 31, 2020 -6.99 Mn
Dec 31, 2019 -9.75 Mn
Sep 30, 2019 -7.30 Mn